SEC Filing Analysis: EXACT SCIENCES CORP (EXAS)

Executive Summary

• Trading Significance: Low
• Key Takeaway: An officer at Exact Sciences has filed a notice of a proposed sale of common stock valued at approximately $200,288. The sale is planned under a pre-established 10b5-1 trading plan, significantly reducing its market signaling power.
• Market Impact: The transaction is of very low materiality and is expected to have a neutral impact on the stock.

Company Information

Field	Value
Company	EXACT SCIENCES CORP
Ticker Symbol	EXAS
CIK	0001124140
Industry	SERVICES-MEDICAL LABORATORIES

Insider Information

Field	Value
Name	Baranick Brian
CIK	0001941313
Title/Position	Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	144
Transaction Date	2025-11-04
Transaction Code	S
Security Type	Common
Shares Involved	2,858
Price Per Share	70.09
Total Value	200288.64
Shares Owned After	null
Ownership Type	null

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$200,288.64
% of Market Cap	0.0016%
Shares Transacted	2,858
% of Shares Outstanding	0.0015%
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a company with a market capitalization of $12.25 billion, this $200k transaction is financially insignificant.
• Transaction Significance: The sale represents a negligible fraction of both the market capitalization (0.0016%) and the total shares outstanding (0.0015%), falling far below any threshold for moderate or high significance.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction is a proposed sale, not a completed one. Its small size and execution under a 10b5-1 plan (adopted 05/13/2024) indicate it is likely for personal financial planning rather than a reaction to non-public information.

Volume & Sentiment

• Expected Volume Impact: Negligible. The number of shares is too small to impact trading volume.
• Sentiment Indicator: Neutral. Pre-planned sales by executives are common and generally not viewed as a bearish signal.

Additional Context

Special Circumstances

• The filing indicates this proposed sale is pursuant to a Rule 10b5-1 trading plan adopted on May 13, 2024. This means the decision to sell was made months in advance, detaching it from the company's current performance.